Tibra Equities Europe’s Galectin Therapeutics GALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-98,700
Closed -$316K 103
2021
Q2
$316K Buy
+98,700
New +$316K 0.1% 156
2019
Q2
Sell
-72,685
Closed -$371K 318
2019
Q1
$371K Buy
+72,685
New +$371K 0.04% 300
2018
Q2
Sell
-63,414
Closed -$301K 143
2018
Q1
$301K Buy
+63,414
New +$301K 0.05% 169